4Pitt B,Zannad F,Remme W J,et al.The effect of spironolactone on the morbidity and mortality in patients with severe heart failure[J].N Eng,J Med,1999,341(10):709
二级参考文献23
1陈国伟 郑宗锷.现代心脏内科学[M].长沙:湖南科技出版社,1995.558.
2Tsutamoto T, Wada A, Maeda K, et al. Effect of spironolactone. On plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure[J]. J Am Coll Cardiol,2001,37(5) : 1228-1233.
3Poulsen S H, Host N S, Jensen S E, et al. Relationship between serum amino-terminal propeptide of type Ⅲ procollagen and changes of left ventricular ruction after acute myocardial infarction[J]. Circulation, 2000,101 ( 9 ) : 1527.
4Mizuno Y, Yoshimura M, Yasue H, et al. Aldosterone production isactivated in failing ventricle in humans[J].Circulation, 2001,103 (10) : 72.
5Mark A. Spironolactone for heart failure[J]. Med Lett Drags Ther, 1999,41 (1061) : 81-82.
6Pitt B, Zannad F, Remme W J, et al. The effect of spironolactone on the morbidity and mortality in patients with severe heart failure[J]. N Eng J Med,1999,341(10) :709.
7Berry C,Mcmurray J J. Serious adverse events experienced by patients with chronic heart failure takin spironolactone [J].Heart,2001,85(4) :8.
8Zannad F, Dousset B, Alia F. Treatment of congestive heart failure. Interfering the aldosterone-cardiac extracellular relationship[J]. Hypertension, 2001,38(11) : 1227.
